Bioseparation is a critical step in biopharmaceutical manufacturing. It employs polymeric adsorbents decorated with affinity ligands to increase the selective capture of target biological products. Current adsorbents result in slow processes with low capacity due to diffusive transport and uncontrolled heterogeneous distribution of affinity ligands. The EU-funded PURE project aims to develop precisely functionalised adsorbents …
On 27th November 2020, researchers across Europe will get closer to the general public, this year in an online format. The PURE project participated in this event, in Portugal, and created a video with Cecília Roque and Margarida Dias explaining to the general public and younger people how to sustainably develop biologic drugs. For more …
PURE coordinator Cecília Roque was invited for an interview on “How to make cheaper and environmentally friendly drugs”. The live interview was in the weekly program “Cromo da Semana”, where high profile people working in science and technology, in Portugal, are invited to talk about their projects to the general public. Watch the video below …
The Pure Project just hit the Portuguese media. The European PURE project received a funding of nearly €3 million to develop sustainable processes to manufacture biopharmaceuticals, which include biological drugs such as antibodies and viral particles, used in cancer treatment and in vaccination, respectively. The project is coordinated by Cecília Roque, Principal Investigator at the …
The PURE Project Kick-Off Meeting took place on 28th & 29th October 2020. Due to the current pandemic, the event was virtual with all partners: NOVA (PT), iBET (PT), BOKU (AT) and Bayreuth (DE).
